Trials / Completed
CompletedNCT03850587
Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phaseII Study to Investigate the Efficacy and Safety of YYC301 in Subject With Knee Osteoarthritis.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 261 (actual)
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phaseII Study to Investigate the Efficacy and Safety of YYC301 in Subject With Knee Osteoarthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Celecoxib 200mg | comparator medication |
| DRUG | Tramadol 37.5Mg+ Celecoxib 200mg | experimental medication |
| DRUG | Tramadol 75mg+ Celecoxib 200mg | experimental medication |
| DRUG | Tramadol 150mg+ Celecoxib 200mg | experimental medication |
Timeline
- Start date
- 2018-08-30
- Primary completion
- 2020-05-12
- Completion
- 2020-09-07
- First posted
- 2019-02-22
- Last updated
- 2021-05-11
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03850587. Inclusion in this directory is not an endorsement.